Loading clinical trials...
Loading clinical trials...
Renal ischemia/reperfusion (I/R)-induced injury is known to be associated with immediate and long-term hepatic dysfunction after liver transplantation. Protecting the liver against I/R injury and maintaining hepatic function during transplant surgery is therefore very important in order to improve post-operative outcome. This purpose of this study is to investigate whether propofol anesthesia done in both liver donors and recipients during living-donor liver transplantation is effective in reducing liver I/R injury via its antioxidant and antiinflammatory properties and improve post-transplant outcome compared to desflurane anesthesia.
Age
20 - No limit years
Sex
ALL
Healthy Volunteers
No
Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine
Seoul, South Korea
Start Date
June 1, 2014
Primary Completion Date
May 1, 2017
Completion Date
May 1, 2017
Last Updated
July 5, 2017
136
ACTUAL participants
Desflurane balanced anesthesia
DRUG
Propofol total intravenous anesthesia
DRUG
Lead Sponsor
Yonsei University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions